Download the Whitepaper

Making the Complex Seamless in
Obesity Clinical Development

With decades of phase I-IV metabolic experience and access to in-house and external data streams, Medpace supports the development and execution of rare to large global obesity trials. Medpace has medical, operations, and regulatory staff who understand the complexities of obesity trials from the perspective of the Sponsor, the patients, the clinical investigator, the scientific leader, and the reviewer at the regulatory agencies. Our matured relationships with global thought leaders, investigative sites, the Medpace global ‘flagship’ metabolic site network, and patient advocacy groups, as well as knowledge of effective patient retention strategies, ensure efficient and quality patient enrollment which is key to the success of these programs.